Dr. James Davis is the Medical Director for Duke Center for Smoking Cessation, Director of the Duke Smoking Cessation Program and Co-Director of the Duke-UNC Tobacco Treatment Specialist Credentialing Program. Dr. Davis is a practicing Hospitalist (Internal Medicine) and is a tobacco dependence instructor for the Duke University School of Nursing, Duke Psychiatry and Family Practice Residency programs. His research has focused on development of mindfulness-based treatments for smoking cessation and he is currently principal investigator on an NIH funded clinical trial assessing “adaptive” quit smoking medication protocols and assessing the effectiveness of an the Duke Smoking Cessation Program. Dr. Davis is Co-Investigator on a trial assessing decision making in Lung Cancer Screening and several trials on the use of E-cigarettes as a treatment for smokers.
Education and Training
- Internal Medicine Residency, Mayo Clinic, 1997 - 2000
- M.D., Southern Illinois University School of Medicine, 1997
- Pfizer Preceptorship
- Randomized-Controlled Smoking Cessation Trial on Varenicline vs. Varenicline-based Adaptive Pharmacotherapy with Cross-Randomization to High vs. Low Intensity Behavioral Therapy
- Duke Cancer Institute Application for Administrative Supplement for the P30 Cancer Center Support Grant to Develop Tobacco Cessation Treatment Capacity and Infrastructure for Cancer Patients
- Davis Tobacco-Free Generation Campus initiative Grant
- Innovations to Increase Utilization of a Smoking Cessation Program ¿ A Retrospective Review
- Tobacco Treatment Specialist Training (Novant Health)
- A Randomized, Double-Blind Study to Evaluate the Impact of AXS-05 on Smoking Behavior.
- Tobacco Treatment Specialist Training (Charlotte)
- Lung Cancer Screening Implementation: Evaluation of Patient-Centered Care
- The Role of Nicotine and Non-Nicotine Alkaloids in E-Cigarette Use and Dependence